Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Fritsche

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cancer|September 1, 1989
Sequential cyclic combined hormonal therapy for metastatic breast cancerG N Hortobagyi, V Hug, A U Buzdar, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cellsA O Hoff, G J Cote, H A Fritsche, et al.
JAMA|April 8, 1983
Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancerA W Mughal, G N Hortobagyi, H A Fritsche, et al.
Diagnostic Cytopathology|May 13, 1999
Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladderJ H Hughes, R L Katz, J Rodriguez-Villanueva, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 6, 1997
The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal modelE G Silva, C Tornos, H A Fritsche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicityI W Dimery, W K Hong, J J Lee, et al.
Cancer Research|March 1, 1994
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancerW J Allard, I E Neaman, J J Elting, et al.
Cancer|April 15, 1991
Monoclonal prostate-specific antigen in untreated prostate cancer. Relationship to clinical stage and gradeR J Babaian, J L Camps, D N Frangos, et al.
Breast Cancer Research and Treatment|May 11, 1990
Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomasR L Katz, S Patel, N Sneige, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assayF A Holmes, H A Fritsche, J W Loewy, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer|September 1, 1989
Sequential cyclic combined hormonal therapy for metastatic breast cancerG N Hortobagyi, V Hug, A U Buzdar, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cellsA O Hoff, G J Cote, H A Fritsche, et al.
JAMA|April 8, 1983
Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancerA W Mughal, G N Hortobagyi, H A Fritsche, et al.
Diagnostic Cytopathology|May 13, 1999
Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladderJ H Hughes, R L Katz, J Rodriguez-Villanueva, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 6, 1997
The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal modelE G Silva, C Tornos, H A Fritsche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicityI W Dimery, W K Hong, J J Lee, et al.
Cancer Research|March 1, 1994
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancerW J Allard, I E Neaman, J J Elting, et al.
Cancer|April 15, 1991
Monoclonal prostate-specific antigen in untreated prostate cancer. Relationship to clinical stage and gradeR J Babaian, J L Camps, D N Frangos, et al.
Breast Cancer Research and Treatment|May 11, 1990
Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomasR L Katz, S Patel, N Sneige, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assayF A Holmes, H A Fritsche, J W Loewy, et al.
Pageof 8